Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5759.98 | 245 / 245 | 100% | 9.45 | 501 / 502 |
brain | 100% | 3740.01 | 2633 / 2642 | 100% | 9.18 | 705 / 705 |
breast | 100% | 4190.39 | 459 / 459 | 100% | 9.85 | 1114 / 1118 |
thymus | 100% | 4955.75 | 653 / 653 | 99% | 6.97 | 598 / 605 |
ovary | 100% | 5407.58 | 180 / 180 | 99% | 6.96 | 425 / 430 |
uterus | 100% | 5197.15 | 170 / 170 | 98% | 7.16 | 452 / 459 |
lung | 100% | 4499.88 | 578 / 578 | 98% | 7.16 | 1137 / 1155 |
bladder | 100% | 4738.19 | 21 / 21 | 98% | 7.11 | 495 / 504 |
esophagus | 100% | 4807.42 | 1445 / 1445 | 98% | 6.20 | 179 / 183 |
pancreas | 100% | 3270.06 | 327 / 328 | 98% | 6.51 | 174 / 178 |
intestine | 100% | 4945.91 | 966 / 966 | 94% | 4.79 | 496 / 527 |
adrenal gland | 100% | 5644.40 | 258 / 258 | 93% | 5.49 | 214 / 230 |
kidney | 100% | 4583.57 | 89 / 89 | 92% | 4.96 | 833 / 901 |
stomach | 100% | 4136.86 | 359 / 359 | 91% | 4.53 | 259 / 286 |
skin | 100% | 4492.57 | 1809 / 1809 | 85% | 4.46 | 400 / 472 |
liver | 100% | 2915.77 | 226 / 226 | 54% | 2.16 | 218 / 406 |
adipose | 100% | 4202.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.75 | 29 / 29 |
muscle | 100% | 3361.78 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5946.09 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.50 | 1 / 1 |
blood vessel | 100% | 3944.91 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2945.41 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 4391.00 | 917 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 5.27 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 75% | 3.38 | 60 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031016 | Biological process | pancreas development |
GO_0035278 | Biological process | miRNA-mediated gene silencing by inhibition of translation |
GO_0006396 | Biological process | RNA processing |
GO_0032055 | Biological process | negative regulation of translation in response to stress |
GO_0051149 | Biological process | positive regulation of muscle cell differentiation |
GO_0035883 | Biological process | enteroendocrine cell differentiation |
GO_0002190 | Biological process | cap-independent translational initiation |
GO_0046685 | Biological process | response to arsenic-containing substance |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0035773 | Biological process | insulin secretion involved in cellular response to glucose stimulus |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0046822 | Biological process | regulation of nucleocytoplasmic transport |
GO_0002192 | Biological process | IRES-dependent translational initiation of linear mRNA |
GO_0045947 | Biological process | negative regulation of translational initiation |
GO_0045727 | Biological process | positive regulation of translation |
GO_0097167 | Biological process | circadian regulation of translation |
GO_0043153 | Biological process | entrainment of circadian clock by photoperiod |
GO_0046626 | Biological process | regulation of insulin receptor signaling pathway |
GO_0017148 | Biological process | negative regulation of translation |
GO_0005730 | Cellular component | nucleolus |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0097157 | Molecular function | pre-mRNA intronic binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0035198 | Molecular function | miRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0030332 | Molecular function | cyclin binding |
GO_0097158 | Molecular function | pre-mRNA intronic pyrimidine-rich binding |
Gene name | RBM4 |
Protein name | RNA binding motif protein 4 RNA-binding protein 4 (Lark homolog) (hLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a) |
Synonyms | RBM4A |
Description | FUNCTION: RNA-binding factor involved in multiple aspects of cellular processes like alternative splicing of pre-mRNA and translation regulation. Modulates alternative 5'-splice site and exon selection. Acts as a muscle cell differentiation-promoting factor. Activates exon skipping of the PTB pre-mRNA during muscle cell differentiation. Antagonizes the activity of the splicing factor PTBP1 to modulate muscle cell-specific exon selection of alpha tropomyosin. Binds to intronic pyrimidine-rich sequence of the TPM1 and MAPT pre-mRNAs. Required for the translational activation of PER1 mRNA in response to circadian clock. Binds directly to the 3'-UTR of the PER1 mRNA. Exerts a suppressive activity on Cap-dependent translation via binding to CU-rich responsive elements within the 3'UTR of mRNAs, a process increased under stress conditions or during myocytes differentiation. Recruits EIF4A1 to stimulate IRES-dependent translation initiation in respons to cellular stress. Associates to internal ribosome entry segment (IRES) in target mRNA species under stress conditions. Plays a role for miRNA-guided RNA cleavage and translation suppression by promoting association of AGO2-containing miRNPs with their cognate target mRNAs. Associates with miRNAs during muscle cell differentiation. Binds preferentially to 5'-CGCGCG[GCA]-3' motif in vitro. . |
Accessions | ENST00000510173.6 ENST00000310092.12 [Q9BWF3-1] E9PB51 ENST00000409406.1 [Q9BWF3-1] ENST00000398692.8 [Q9BWF3-3] ENST00000408993.6 [Q9BWF3-1] Q9BWF3 D6R9K7 ENST00000506523.6 ENST00000532968.1 [Q9BWF3-2] ENST00000530235.1 [Q9BWF3-3] J3QRR5 ENST00000483858.5 [Q9BWF3-2] ENST00000578778.5 ENST00000396053.9 [Q9BWF3-4] |